Biden Administration To Boost Antivirals Amid Rising COVID Cases - medtigo


Biden Administration To Boost Antivirals Amid Rising COVID Cases

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Amid a rise in the COVID cases, the Biden administration has decided to double the pharmacies that avail antiviral pills to fight COVID-19. The decision was taken after many consumers reported problems finding the pharmacy or doctors to prescribe the pill. 

Moreover, Pfizer’s COVID pill Paxlovid will be available at pharmacies. People can take this pill for five days after testing positive for the coronavirus. 

During the omicron wave, this drug was in huge demand. The demand for this drug has increased again as the omicron subvariant BA.2 is infecting more and more people throughout the world. The average weekly cases rose from 38,000 to 41,000 in one week, as reported by the Washington Post. 

The actions by the federal government were taken after people expressed difficulties in getting the pill. The demand for this drug rose after many studies suggested that taking this pill can reduce the chances of hospitalization and reduced the chances of death by 90 percent. 

The administration claims that the drug is in ample supply, but the patients have claimed that they are still facing problems in getting the drug. 

Currently, the pills are available at 20,000 locations across the nation. However, in some areas, the drug centres are about 100 miles away. The federal government says that it is planning to make this drug available at 30,000 locations and eventually at about 40,000 centres in the subsequent weeks. 

On Monday, the Centers for Disease Control and Prevention advised physicians not to use certain types of treatments, including antibiotics, in patients with covid. 

The federal agency acknowledged the difficulty that Americans are facing and promised to make the drug available in the coming weeks. Also, the agency told people to take the pill within the first 5 days of contracting the virus or getting the symptoms, the Washington Post reports. 

There is a noticeable shortage of antivirals in the states. Several doctors have reported problems in getting the antivirals to give to the vulnerable cases, especially the older people. 


Leave a Reply